Medinova Diagnostic Service Intrinsic Value
Medinova Diagnostic Service (MEDINOV) median intrinsic value is ₹23.90 from 6 valuation models (range ₹13–₹35), vs current price ₹44.01 — -45.7% downside (Trading Above Calculated Value), margin of safety -84.1%. For current market price and key ratios, visit MEDINOV stock overview.
MEDINOV Valuation Methods Summary — DCF, Graham Number & P/E
Medinova Diagnostic Service intrinsic value across 6 models vs current price ₹44.01 — upside/downside and value range per method. Browse MEDINOV complete financial for revenue, profit, balance sheet and cash flow data.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹24.96 | ₹19.97 - ₹29.95 | -43.3% | EPS: ₹2.08, Sector P/E: 12x |
| Revenue Multiple Method | revenue | ₹13.20 | ₹11.88 - ₹14.52 | -70.0% | Revenue/Share: ₹12.00, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹23.90 | ₹21.51 - ₹26.29 | -45.7% | EBITDA: ₹4.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹34.64 | ₹27.71 - ₹41.57 | -21.3% | CF Growth: 10.7%, Discount: 15% |
| PEG Ratio Method | growth | ₹13.31 | ₹11.98 - ₹14.64 | -69.8% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹17.14 | ₹15.43 - ₹18.85 | -61.1% | Revenue Growth: 6.0%, Adj P/E: 8.2x |
MEDINOV Intrinsic Value vs Market Price — All Valuation Models
Medinova Diagnostic Service fair value range ₹13–₹35 vs current market price ₹44.01 across 6 valuation models. Compare with MEDINOV DCF to assess whether the stock is under or overvalued.
MEDINOV Intrinsic Value Analysis — Undervalued or Overvalued?
Medinova Diagnostic Service median intrinsic value ₹23.90, current price ₹44.01 — Trading Above Calculated Value by 45.7%, margin of safety -84.1%.
What is the intrinsic value of MEDINOV?
Based on our comprehensive analysis using 6 different valuation methods, the estimated intrinsic value of Medinova Diagnostic Service (MEDINOV) is ₹23.90 (median value). With the current market price of ₹44.01, this represents a -45.7% variance from our estimated fair value.
The valuation range spans from ₹13.20 to ₹34.64, indicating ₹13.20 - ₹34.64.
Is MEDINOV undervalued or overvalued?
Based on our multi-method analysis, Medinova Diagnostic Service (MEDINOV) appears to be trading above calculated value by approximately 45.7%.
MEDINOV Financial Health — Key Ratios vs Industry Benchmarks
Medinova Diagnostic Service financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 0.80 | Industry Standard: 2.0+ | Below 1.5 | Measures short-term liquidity capacity |
| Debt to Equity Ratio | -7.00 | Industry Standard: <0.5 | Below 0.5 | Indicates financial leverage level |
| Return on Equity | -400.0% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | 37.0% | Industry Standard: 20%+ | Above 20% | Indicates operational efficiency level |
| Asset Turnover Ratio | 1.71x | Industry Standard: 1.0x+ | Above 1.0x | Measures asset utilization efficiency |
MEDINOV Cash Flow Quality — Operating & Free Cash Flow
Medinova Diagnostic Service operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹3 Cr | ₹2 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹3 Cr | ₹3 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹1 Cr | ₹1 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹1 Cr | ₹0 Cr | Positive Operating Cash Flow | 6/10 |
| March 2021 | ₹2 Cr | ₹2 Cr | Positive Free Cash Flow | 8/10 |